Holen Sie sich die Stockscreener-App
1.36
6.85%
-0.10
Schlusskurs vom Vortag:
$1.46
Offen:
$1.42
24-Stunden-Volumen:
3.91M
Relative Volume:
1.72
Marktkapitalisierung:
$1.08B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-7.1579
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
-9.33%
1M Leistung:
-12.26%
6M Leistung:
-1.45%
1J Leistung:
-9.93%
1-Tages-Spanne:
$1.35
$1.44
1-Wochen-Bereich:
$1.35
$1.51
52-Wochen-Spanne:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Vergleichen Sie OPK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.36 | 1.12B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
Is OPKO Health Inc. (XCY) stock a defensive play amid uncertainty2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
OPKO Health (NASDAQ:OPK) Rating Increased to Hold at Wall Street Zen - MarketBeat
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Will OPKO Health Inc. (XCY) stock beat growth indexes2025 Performance Recap & High Accuracy Trade Alerts - newser.com
Can OPKO Health Inc. (XCY) stock double in coming yearsWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Can OPKO Health Inc. (XCY) stock hold up in economic slowdownProfit Target & Step-by-Step Trade Execution Guides - newser.com
Is OPKO Health Inc. building a consolidation basePortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Can technical indicators confirm OPKO Health Inc.’s reversalQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Top chart patterns to watch in OPKO Health Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Can a trend reversal in OPKO Health Inc. lead to recoveryBull Run & Verified Technical Signals - newser.com
Will OPKO Health Inc. stock benefit from green energy trendsQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Regression analysis insights on OPKO Health Inc. performanceSwing Trade & Reliable Trade Execution Plans - newser.com
Opko Health director Frost buys $213k in shares By Investing.com - Investing.com Canada
OPKO Health, Inc. (OPK) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Opko Health director Frost buys $213k in shares - Investing.com
OPKO Health Reports Q3 2025 Earnings and Strategic Moves - MSN
Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance
OPKO Health Shares Fall After Jefferies Downgrade - MarketScreener
Jefferies Downgrades OPK: Price Target Lowered by 20% | OPK Stoc - GuruFocus
Barrington Research Reiterates "Outperform" Rating for OPKO Health (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q3 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
Will OPKO Health Inc. (XCY) stock enhance shareholder valueMarket Performance Summary & Precise Swing Trade Alerts - newser.com
When is the best time to exit OPKO Health Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
How to read the order book for OPKO Health Inc.Quarterly Profit Review & Smart Allocation Stock Tips - newser.com
Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - MSN
OPKO Health (OPK): Losses Accelerate 25% Annually, Revenue Forecast Trails Market Ahead of Earnings - Yahoo Finance
Is OPKO Health Inc. stock supported by strong fundamentalsJuly 2025 Institutional & Weekly Breakout Watchlists - newser.com
OPKO Health Inc (OPK) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Performance By GuruFocus - Investing.com Canada
Jefferies downgrades Opko Health stock to Hold on flat Ngenla sales - Investing.com Nigeria
OPKO Health (NASDAQ:OPK) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands - Yahoo Finance
How OPKO Health Inc. (XCY) stock performs during market turbulenceJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
How to use Fibonacci retracement on OPKO Health Inc.Trade Risk Assessment & Capital Efficiency Focused Ideas - newser.com
Barrington Research Maintains OPKO Health (OPK) Outperform Recommendation - Nasdaq
OPKO Health: Q3 Earnings Snapshot - theheraldreview.com
Published on: 2025-10-29 21:45:43 - newser.com
OPKO Health Q3 Earnings Preview - MSN
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics - sharewise.com
OPKO Health Swaps Lab Assets And Trims Costs For Steadier Profits - Finimize
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Opko Health Inc-Aktie (OPK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
0.11%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):